1. Nothing about any new deals landed in the past six months
2. Big empty promises about expanding into pharmaceuticals (laughable) and vaccines (even more laughable).
3. Nothing but excuses and half-hearted attempts at sounding like a real company. Backorders, delays, future deals maybe but not sure of ability to fulfill, blah, blah, blah.
In short, CLASSIC Aurelio...nothing real to announce, just fluff and hopes and dreams.
In closing, thank you investors for allowing me to keep paying myself rich consulting fees without results!